Basit öğe kaydını göster

Botulinum toxin for the treatment of temporomandibular joint disk disfigurement: Clinical experience

dc.contributor.authorKaracalar, A
dc.contributor.authorYilmaz, N
dc.contributor.authorBilgici, A
dc.contributor.authorBas, B
dc.contributor.authorAkan, H
dc.date.accessioned2020-06-21T15:37:00Z
dc.date.available2020-06-21T15:37:00Z
dc.date.issued2005
dc.identifier.issn1049-2275
dc.identifier.issn1536-3732
dc.identifier.urihttps://doi.org/10.1097/04.SCS.0000157263.73768.64
dc.identifier.urihttps://hdl.handle.net/20.500.12712/21120
dc.descriptionBAS, BURCU/0000-0003-0593-3400en_US
dc.descriptionWOS: 000229555600029en_US
dc.descriptionPubMed: 15915120en_US
dc.description.abstractType A botulinum toxin was used for the treatment of symptoms of 26 patients (40 joints) with temporomandibular joint disk disfigurement. In all patients, 0.5 ml (12.5 U) was injected into the lateral pterygoid muscle. The temporalis, medial pterygoid, and masseter muscles were injected if severe tenderness was noted.en_US
dc.language.isoengen_US
dc.publisherLippincott Williams & Wilkinsen_US
dc.relation.isversionof10.1097/04.SCS.0000157263.73768.64en_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectbotulinum toxinen_US
dc.subjecttemporomandibular jointen_US
dc.subjectdisk displacementen_US
dc.subjectpainen_US
dc.titleBotulinum toxin for the treatment of temporomandibular joint disk disfigurement: Clinical experienceen_US
dc.typearticleen_US
dc.contributor.departmentOMÜen_US
dc.identifier.volume16en_US
dc.identifier.issue3en_US
dc.identifier.startpage476en_US
dc.identifier.endpage481en_US
dc.relation.journalJournal of Craniofacial Surgeryen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster